Statements (101)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:medical_devices
|
gptkbp:approves |
gptkb:FDA
|
gptkbp:based_on |
transient elastography
|
gptkbp:can_be_combined_with |
other diagnostic tests
other imaging techniques |
gptkbp:can_detect |
cirrhosis
steatosis |
gptkbp:developed_by |
gptkb:Echosens
|
gptkbp:evaluates |
liver fibrosis
|
gptkbp:has_a_learning_curve_for |
operators
|
https://www.w3.org/2000/01/rdf-schema#label |
Fibro Scan
|
gptkbp:is |
a treatment
|
gptkbp:is_a_diagnostic_tool_for |
hepatology
|
gptkbp:is_a_guide_for |
clinical decisions
|
gptkbp:is_a_non-invasive_alternative_to |
invasive procedures
|
gptkbp:is_a_preferred_method_for |
liver assessment
|
gptkbp:is_a_tool_for |
liver disease management
supports liver health monitoring |
gptkbp:is_analyzed_in |
treatment response
portal hypertension |
gptkbp:is_applicable_to |
chronic liver diseases
|
gptkbp:is_associated_with |
patient comfort
faster diagnosis lower patient discomfort |
gptkbp:is_available_for |
outpatient use
|
gptkbp:is_available_in |
many countries
|
gptkbp:is_based_on |
transient elastography
|
gptkbp:is_considered |
clinical studies
standard of care |
gptkbp:is_effective_against |
evaluating treatment response
detecting cirrhosis monitoring liver disease progression |
gptkbp:is_influenced_by |
body mass index
|
gptkbp:is_not_invasive |
gptkb:true
|
gptkbp:is_often_used_in |
ultrasound imaging
|
gptkbp:is_part_of |
liver disease management
liver health assessment routine liver evaluation liver assessment protocols |
gptkbp:is_recognized_by |
gptkb:guidelines
|
gptkbp:is_recommended_by |
gptkb:guidelines
liver biopsy |
gptkbp:is_subject_to |
regulatory approval
|
gptkbp:is_tested_for |
is cost-effective
can be performed in outpatient settings can be repeated over time |
gptkbp:is_used_by |
gptkb:healthcare_professionals
|
gptkbp:is_used_in |
gptkb:hepatitis_C
hospitals research studies clinical trials clinical settings primary care settings nonalcoholic fatty liver disease specialist clinics chronic liver disease |
gptkbp:is_used_to |
guide treatment decisions
assess liver fat content assess liver fibrosis in diabetes patients assess liver health assess risk of liver-related complications determine liver stiffness score evaluate liver fibrosis stage evaluate liver inflammation evaluate liver transplant candidacy monitor liver conditions monitor response to antiviral therapy screen for liver cancer screen for liver disease assess liver stiffness in patients with metabolic syndrome evaluate liver stiffness in alcohol-related liver disease |
gptkbp:is_validated_against |
liver biopsy results
|
gptkbp:manufacturer |
gptkb:Echosens
|
gptkbp:measures |
liver stiffness
|
gptkbp:monitors |
liver disease progression
|
gptkbp:non_invasive |
gptkb:true
|
gptkbp:notable_technology |
is user-friendly
is widely used in hepatology. uses ultrasound waves |
gptkbp:performed_by |
trained healthcare professionals
|
gptkbp:provides |
quantitative results
quantitative measurement |
gptkbp:requires |
patient cooperation
trained operator |
gptkbp:result |
minutes
|
gptkbp:security |
patients
most patients |
gptkbp:specialties |
requires minimal preparation
provides immediate feedback |
gptkbp:suitable_for |
certain patients
certain patients with ascites |
gptkbp:technique |
enhances liver disease diagnosis
improves diagnostic accuracy reduces patient anxiety |
gptkbp:technology |
improves patient outcomes
is continually evolving |
gptkbp:transportation |
gptkb:true
|
gptkbp:used_for |
non-invasive assessment
assessing liver stiffness diagnosing liver fibrosis |
gptkbp:wildlife |
gptkb:true
|